Pfizer (PFE) Shares Outstanding (Weighted Average) (2009 - 2026)

Pfizer (PFE) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $5.7 billion in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $5.7 billion, changed 0.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.7 billion (changed 0.28% YoY), and the FY2025 annual result was $5.7 billion, changed 0.34% from the prior year.
• Shares Outstanding (Weighted Average) held at $5.7 billion in Q1 2026 per PFE's latest filing, from $5.7 billion in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $5.7 billion in Q1 2026 and troughed at $5.6 billion in Q3 2022.
• A 5-year average of $5.7 billion and a median of $5.7 billion in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) grew 0.12% in 2022, then advanced 0.73% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $5.6 billion in 2022, then rose by 0.62% to $5.6 billion in 2023, then climbed by 0.37% to $5.7 billion in 2024, then increased by 0.34% to $5.7 billion in 2025, then advanced by 0.14% to $5.7 billion in 2026.
• Business Quant data shows PFE's Shares Outstanding (Weighted Average) at $5.7 billion in Q1 2026, $5.7 billion in Q4 2025, and $5.7 billion in Q3 2025.